MENU

RNTX Rein Therapeutics Inc Forecast, Technical & Fundamental Analysis

Rein Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing novel therapies for the treatment of orphan pulmonary and fibrosis indications with no approved or limited effective treatments... Show more

RNTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
RNTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

RNTX is expected to report earnings to fall 10.00% to -9 cents per share on November 13

Rein Therapeutics Inc RNTX Stock Earnings Reports
Q3'26
Est.
$-0.09
Q2'26
Beat
by $0.39
Q4'25
Missed
by $0.92
Q3'25
Missed
by $0.01
Q2'25
Missed
by $0.07
The last earnings report on August 14 showed earnings per share of -10 cents, beating the estimate of -49 cents. With 385.00K shares outstanding, the current market capitalization sits at 70.57M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SIIEX24.890.33
+1.34%
Touchstone International Value Y
TSOHX17.570.18
+1.04%
Nuveen International Res Eq I
RPPRX36.070.18
+0.50%
Victory RS Partners R6
WIREX26.440.05
+0.19%
Wireless
APHIX34.520.02
+0.06%
Artisan International Institutional

RNTX and Stocks

Correlation & Price change

A.I.dvisor tells us that RNTX and PRLD have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RNTX and PRLD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNTX
1D Price
Change %
RNTX100%
+3.07%
PRLD - RNTX
30%
Poorly correlated
+2.00%
CBIO - RNTX
26%
Poorly correlated
+5.67%
PDSB - RNTX
25%
Poorly correlated
+4.60%
ABOS - RNTX
25%
Poorly correlated
-0.94%
SRPT - RNTX
25%
Poorly correlated
-2.24%
More
Rein Therapeutics (RNTX) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com